<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptors (PPARs) are involved in energy expenditure, regulation of inflammatory processes, and cellular protection in peripheral tissues </plain></SENT>
<SENT sid="1" pm="."><plain>Among the different types of PPARs, PPARbeta is the only one to be widely expressed in cortical neurons </plain></SENT>
<SENT sid="2" pm="."><plain>Using PPARbeta knockout (KO) mice, we report here a detailed investigation of the role of PPARbeta in cerebral ischemic damage, associated inflammatory and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> processes as well as food intake regulation after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>The PPARbeta KO mice had a two-fold increase in <z:mpath ids='MPATH_124'>infarct</z:mpath> size compared with <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice </plain></SENT>
<SENT sid="4" pm="."><plain>Brain <z:mp ids='MP_0003674'>oxidative stress</z:mp> was dramatically enhanced in these KO mice, as documented by an increased content of malondialdehyde, decreased levels of <z:chebi fb="0" ids="16856">glutathione</z:chebi> and <z:chebi fb="70" ids="18291,35154">manganese</z:chebi> <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, and no induction of uncoupling protein 2 (UCP2) <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Unlike WT mice, PPARbeta KO mice showed a marked increase of prooxidant interferon-gamma but no induction of nerve growth factor and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha after MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>In WT mice, MCAO resulted in <z:mp ids='MP_0001845'>inflammation</z:mp>-specific transient <z:hpo ids='HP_0002591'>hyperphagia</z:hpo> from day 3 to day 5 after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, which was associated with an increase in neuropeptide Y (NPY) <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>This hyperphagic phase and NPY <z:chebi fb="2" ids="33699">mRNA</z:chebi> induction were not observed in PPARbeta KO mice </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, our study also suggests for the first time that UCP2 is involved in MCAO food intake response </plain></SENT>
<SENT sid="9" pm="."><plain>These data indicate that PPARbeta plays an important role in integrating and regulating central <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:chebi fb="11" ids="22586">antioxidant</z:chebi> mechanisms, and food intake after MCAO, and suggest that the use of PPARbeta <z:chebi fb="4" ids="48705">agonists</z:chebi> may be of interest for the prevention of central ischemic damage </plain></SENT>
</text></document>